SCIG

SCIG is a purified immunoglobulin that is injected into the subcutaneous (fatty) area under your skin.

It is made from human plasma. SCIG contains antibodies (immunoglobulins) which are found in the blood to help fight bacteria, fungi, and viruses.

It is used with people who have primary immune deficiency (PID) or secondary immune deficiency (usually due to certain cancers). Immune deficiency is a condition in which a person’s natural defense system or immune system does not function properly and is unable to make enough antibodies, leaving them more vulnerable to infections. SCIG replaces these antibodies, making people with immune deficiency less likely to develop an infection.

Learn more about the SK IVIG Optimization Program.

Resources

Document Name Date of Original Publication Date Revised

Cuvitru Doctor Letter May 29, 2018 May 29, 2018 Download
Cuvitru Patient Letter May 29, 2018 May 29, 2018 Download
Saskatchewan Immunoglobulin Therapy Options February 2, 2018 March 20, 2018 Download
Subcutaneous Immune Globulin (SCIG) Information for Patients and Caregivers February 2, 2018 March 20, 2018 Download

    SCIG SaskBlood Correspondence

    Document Name Date of Original Publication Date Revised

    Subcutaneous and Intravenous Immune Globulin Brand Changes May 29, 2018 May 29, 2018 Download

      Canadian Blood Services Correspondence

      Document Name Date of Original Publication Date Revised
      CBS Customer Letter 2018-35 - SCIG Transition Update August 27, 2018 August 27, 2018 Download